Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: the WATCH-DM risk score MW Segar, M Vaduganathan, KV Patel, DK McGuire, J Butler, ... Diabetes care 42 (12), 2298-2306, 2019 | 159 | 2019 |
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis MW Segar, KV Patel, C Ayers, M Basit, WHW Tang, D Willett, J Berry, ... European journal of heart failure 22 (1), 148-158, 2020 | 156 | 2020 |
TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells H Cardenas, E Vieth, J Lee, M Segar, Y Liu, KP Nephew, D Matei Epigenetics 9 (11), 1461-1472, 2014 | 156 | 2014 |
Epigenetic targeting of ovarian cancer stem cells Y Wang, H Cardenas, F Fang, S Condello, P Taverna, M Segar, Y Liu, ... Cancer research 74 (17), 4922-4936, 2014 | 147 | 2014 |
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer M de Leon, H Cardenas, E Vieth, R Emerson, M Segar, Y Liu, K Nephew, ... Gynecologic oncology 142 (3), 539-547, 2016 | 54 | 2016 |
Development and validation of machine learning–based race-specific models to predict 10-year risk of heart failure: a multicohort analysis MW Segar, BC Jaeger, KV Patel, V Nambi, CE Ndumele, A Correa, ... Circulation 143 (24), 2370-2383, 2021 | 45 | 2021 |
Deep-learning models for the echocardiographic assessment of diastolic dysfunction A Pandey, N Kagiyama, N Yanamala, MW Segar, JS Cho, M Tokodi, ... Cardiovascular Imaging 14 (10), 1887-1900, 2021 | 43 | 2021 |
Rifampin regulation of drug transporters gene expression and the association of microRNAs in human hepatocytes EA Benson, MT Eadon, Z Desta, Y Liu, H Lin, KS Burgess, MW Segar, ... Frontiers in pharmacology 7, 111, 2016 | 42 | 2016 |
Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT Trial MW Segar, KV Patel, JD Berry, JL Grodin, A Pandey Circulation 139 (15), 1851-1853, 2019 | 40 | 2019 |
Age‐related changes in MicroRNA expression and pharmacogenes in human liver KS Burgess, S Philips, EA Benson, Z Desta, A Gaedigk, R Gaedigk, ... Clinical Pharmacology & Therapeutics 98 (2), 205-215, 2015 | 38 | 2015 |
Gender-based differences in outcomes among resuscitated patients with out-of-hospital cardiac arrest P Mody, A Pandey, AS Slutsky, MW Segar, A Kiss, P Dorian, J Parsons, ... Circulation 143 (7), 641-649, 2021 | 35 | 2021 |
Association of long-term change and variability in glycemia with risk of incident heart failure among patients with type 2 diabetes: a secondary analysis of the ACCORD trial MW Segar, KV Patel, M Vaduganathan, MC Caughey, J Butler, ... Diabetes Care 43 (8), 1920-1928, 2020 | 32 | 2020 |
Frailty status modifies the efficacy of exercise training among patients with chronic heart failure and reduced ejection fraction: an analysis from the HF-ACTION trial A Pandey, MW Segar, S Singh, GR Reeves, C O’Connor, I Piña, ... Circulation 146 (2), 80-90, 2022 | 23 | 2022 |
Association of genetic West African ancestry, blood pressure response to therapy, and cardiovascular risk among self-reported black individuals in the Systolic Blood Pressure … S Rao, MW Segar, AP Bress, P Arora, W Vongpatanasin, V Agusala, ... JAMA cardiology 6 (4), 388-398, 2021 | 23 | 2021 |
Incorporation of natriuretic peptides with clinical risk scores to predict heart failure among individuals with dysglycaemia MW Segar, MS Khan, KV Patel, M Vaduganathan, V Kannan, D Willett, ... European Journal of Heart Failure 24 (1), 169-180, 2022 | 19 | 2022 |
Spectral probabilities of top-down tandem mass spectra X Liu, MW Segar, SC Li, S Kim BMC genomics 15 (1), 1-9, 2014 | 18 | 2014 |
Frailty, guideline-directed medical therapy, and outcomes in HFrEF: from the GUIDE-IT trial MS Khan, MW Segar, MS Usman, S Singh, SJ Greene, GC Fonarow, ... Heart Failure 10 (4), 266-275, 2022 | 16 | 2022 |
Association of visit-to-visit variability in kidney function and serum electrolyte indexes with risk of adverse clinical outcomes among patients with heart failure with … MW Segar, RB Patel, KV Patel, M Fudim, AD DeVore, P Martens, ... JAMA cardiology 6 (1), 68-77, 2021 | 16 | 2021 |
Prevalence and prognostic implications of diabetes with cardiomyopathy in community-dwelling adults MW Segar, MS Khan, KV Patel, J Butler, WHW Tang, M Vaduganathan, ... Journal of the American College of Cardiology 78 (16), 1587-1598, 2021 | 14 | 2021 |
Prefrailty, impairment in physical function, and risk of incident heart failure among older adults MW Segar, S Singh, P Goyal, SL Hummel, MS Maurer, DE Forman, ... Journal of the American Geriatrics Society 69 (9), 2486-2497, 2021 | 14 | 2021 |